Breast Cancer
New breast cancer study results reported from Japan, Russia and Austria
Published in Oncology Business Week, February 25th, 2007
Study 1: Investigators publish new data in the report "Quantitative analysis of aromatase, sulfatase and 17beta-HSD(1) mRNA expression in soft tissue metastases of breast cancer." According to a study from Osaka, Japan, "Expression of the estrogen-synthesizing genes aromatase, steroid sulfatase (STS) and 17beta-hydroxysteroid dehydrogenase type1 (17beta-HSD(1)) has been shown to be up-regulated in primary breast cancer tissue but their expression status in metastatic tumor tissue has yet to be determined. The mRNA expression levels of the three estrogen-synthesizing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- Accreditation
Healthways receives NCQA full accreditation for depression and oncology - Actinic Keratoses
International guidelines recommend PDT as first-line treatment for actinic keratoses - Angiogenesis
Study data from Eli Lilly and Company provide new insights into angiogenesis - Brain Cancer
Callisto Pharmaceutical's Degrasyn class has potential to treat brain tumors - Brain Cancer Epidemiology
Research on brain cancer epidemiology detailed by scientists at Eli Lilly and Company - Breast Cancer
Board recommends continuation of Entremed's MKC-1 Phase II breast cancer study - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
